This biotech stock is back in a buy zone after a sharp sell-off. The company makes an obesity drug and develops treatments ...

Food and Beverages, Animal Nutrition, and Personal Care), and Geography", published by The Insight Partners. Overview of ...

Consumer companies fell amid concerns about President-elect Donald Trump's planned appointments.

Snack-and-soda titans PepsiCo and Coca-Cola dropped more than 3% and 1%, respectively, in late day trading Friday. Cheerio ...

The immediate aftermath of the nomination saw vaccine stock prices drop on account of Kennedy’s well-publicized views on ...

Benchmark Co. analyst Todd Brooks maintained a Buy rating on J & J Snack Foods (JJSF – Research Report) today and set a price target of $200.00. The company’s shares closed yesterday at $166.50.

The October PPI ex-food and energy increased by +3.1% year over year, which was more than the +3.0% predicted. •The greenback ...

EURUSD showed a minor pullback post an upbeat US PPI. It hit a fresh year low of 1.04948 at the time of writing and is ...

Analyst Chris Li CFA of Desjardins maintained a Hold rating on Loblaw Companies (LBLCF – Research Report), with a price target of ...

"The markets were on a roar coming into the election, and now they are on a postelection high, really trading on euphoria ...

Removing zelnecirnon means the biotech’s sole remaining clinical-stage asset is tivumecirnon, a phase 2 oncology med being ...